Particle.news
Corporate Accountability Public Health Corporate Influence Consumer Protection Consumer Rights Public Health Issues Corporate Responsibility Government Oversight Emergency Care Medicare Advantage Affordable Care Act Public Opinion Legislative Challenges Consumer Advocacy Industry Practices Corporate Lobbying Public Debate Market Pressures Public vs Private Insurance Public Sentiment Medicare Reform Pharmaceutical Pricing Patient Rights Economic Impact
The insurer's stock plunges over 6% following a Guardian investigation, as CMS announces expanded audits and leadership struggles continue.
